A frequent toll-like receptor 1 gene polymorphism affects nk- and t-cell ifn-γ production and is associated with helicobacter pylori-induced gastric disease

Helicobacter

Volumn 18, Issue 1, 2013, Pages 13-21

  Yang, Chin An ^a   Scheibenbogen, Carmen ^a   Bauer, Sandra ^a   Kleinle, Christoph ^a   Wex, Thomas ^b   Bornschein, Jan ^b   Malfertheiner, Peter ^b   Hellmig, Stephan ^c   Schumann, Ralf R ^a   Hamann, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Schlei Klinikum Schleswig MLK   (Germany)

Author keywords

Gastric cancer; Genetic susceptibility; Immune response; Peptic ulcer

Indexed keywords

GAMMA INTERFERON; TOLL LIKE RECEPTOR 9;

ADULT; AGED; ARTICLE; BACTERIAL GENE; CYTOKINE PRODUCTION; FEMALE; GASTRITIS; GENE FREQUENCY; GENOTYPE; HELICOBACTER PYLORI; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PEPTIC ULCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH DISEASE; STOMACH ULCER; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH DISEASES; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 1;

HELICOBACTER PYLORI;

EID: 84872372112     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12001     Document Type: Article

References (44)

1. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 2010;11:373-84.
2. Schroder NW, Schumann RR. Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005;5:156-64.
3. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007;178:7520-4.
4. Hawn TR, Misch EA, Dunstan SJ, et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007;37:2280-9.
5. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011;16(Suppl. 1):1-9.
6. Amedei A, Cappon A, Codolo G, et al. The neutrophil-activating protein of Helicobacter pylori promotes th1 immune responses. J Clin Invest 2006;116:1092-101.
7. Muller A, Solnick JV. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 2011;16(Suppl. 1):26-32.
8. Watanabe T, Asano N, Kitani A, Fuss IJ, Chiba T, Strober W. Activation of type IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection. Gut Microbes 2011;2:61-5.
9. O'Keeffe J, Moran AP. Conventional, regulatory, and unconventional t cells in the immunologic response to Helicobacter pylori. Helicobacter 2008;13:1-19.
10. Sayi A, Kohler E, Hitzler I, Arnold I, Schwendener R, Rehrauer H, Muller A. The CD4 + t cell-mediated IFN-gamma response to helicobacter infection is essential for clearance and determines gastric cancer risk. J Immunol 2009;182:7085-101.
11. Yun CH, Lundgren A, Azem J, Sjoling A, Holmgren J, Svennerholm AM, Lundin BS. Natural killer cells and Helicobacter pylori infection: Bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect Immun 2005;73:1482-90.
12. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134:306-23.
13. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
14. Hellmig S, Titz A, Steinel S, Ott S, Folsch UR, Hampe J, Schreiber S. Influence of il-1 gene cluster polymorphisms on the development of H. Pylori associated gastric ulcer. Immunol Lett 2005;100:107-12.
15. Hofner P, Gyulai Z, Kiss ZF, et al. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007;12:124-31.
16. Resende C, Ristimaki A, Machado JC. Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter 2010;15(Suppl. 1):34-9.
17. Wang N, Zhou R, Wang C, Guo X, Chen Z, Yang S, Li Y. -251 t/a polymorphism of the interleukin-8 gene and cancer risk: a huge review and meta-analysis based on 42 case-control studies. Mol Biol Rep 2011;39:2831-2841.
18. Viala J, Chaput C, Boneca IG, et al. NOD1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004;5:1166-74.
19. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM. Helicobacter pylori activates toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 2003;71:3496-502.
20. Smith MF Jr, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S, Goldberg JB. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced nf-kappa b activation and chemokine expression by epithelial cells. J Biol Chem 2003;278:32552-60.
21. Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA. Intact gram-negative Helicobacter pylori, helicobacter felis, and helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 2004;72:6446-54.
22. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K. Highly-purified Helicobacter pylori lps preparations induce weak inflammatory reactions and utilize toll-like receptor 2 complex but not toll-like receptor 4 complex. FEMS Immunol Med Microbiol 2007;51:140-8.
23. Tahara T, Arisawa T, Wang F, Shibata T, Nakamura M, Sakata M, Hirata I, Nakano H. Toll-like receptor 2 -196 to 174 del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 2007;98:1790-4.
24. Wex T, Leodolter A, Bornschein J, Kuester D, Kahne T, Kropf S, Albrecht C, Naumann M, Roessner A, Malfertheiner P. Interleukin 1 beta (il1b) gene polymorphisms are not associated with gastric carcinogenesis in Germany. Anticancer Res 2010;30:505-11.
25. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
26. Meining A, Bayerdorffer E, Muller P, Miehlke S, Lehn N, Holzel D, Hatz R, Stolte M. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-4.
27. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
28. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S. Association study of a functional toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 2005;46:869-72.
29. Hamann L, Hamprecht A, Gomma A, Schumann RR. Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the toll-like receptor -2, -4, and -9 genes. J Immunol Methods 2004;285:281-91.
30. Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E, Uharek L. Cd56dimcd16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 2005;19:835-40.
31. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531-7.
32. Lauzon NM, Mian F, MacKenzie R, Ashkar AA. The direct effects of toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 2006;241:102-12.
33. MacLeod H, Wetzler LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE 2007;402:pe48.
34. Girart MV, Fuertes MB, Domaica CI, Rossi LE, Zwirner NW. Engagement of TLR3, TLR7, and nkg2d regulate IFN-gamma secretion but not nkg2d-mediated cytotoxicity by human nk cells stimulated with suboptimal doses of il-12. J Immunol 2007;179:3472-9.
35. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. Tlr2 is expressed on activated t cells as a costimulatory receptor. Proc Natl Acad Sci U S A 2004;101:3029-34.
36. Imanishi T, Hara H, Suzuki S, Suzuki N, Akira S, Saito T. Cutting edge: Tlr2 directly triggers th1 effector functions. J Immunol 2007;178:6715-9.
37. Lindgren A, Pavlovic V, Flach CF, Sjoling A, Lundin S. Interferon-gamma secretion is induced in il-12 stimulated human nk cells by recognition of Helicobacter pylori or TLR2 ligands. Innate Immun 2011;17:191-203.
38. Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI. The polymorphism p315l of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol 2007;178:6387-94.
39. Wurfel MM, Gordon AC, Holden TD, et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008;178:710-20.
40. Pino-Yanes M, Corrales A, Casula M, et al. Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS ONE 2010;5:e13759.
41. Randhawa AK, Shey MS, Keyser A, et al. Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants. PLoS Pathog 2011;7:e1002174.
42. Barreiro LB, Ben-Ali M, Quach H, et al. Evolutionary dynamics of human toll-like receptors and their different contributions to host defense. PLoS Genet 2009;5:e1000562.
43. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007;117:60-9.
44. Stevens VL, Hsing AW, Talbot JT, Zheng SL, Sun J, Chen J, Thun MJ, Xu J, Calle EE, Rodriguez C. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer 2008;123:2644-50.